IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.565
AS - Asia 13.379
EU - Europa 11.746
SA - Sud America 3.187
AF - Africa 347
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 52.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.459
SG - Singapore 4.725
IT - Italia 3.514
CN - Cina 3.263
RU - Federazione Russa 3.204
BR - Brasile 2.499
VN - Vietnam 1.934
GB - Regno Unito 1.407
BD - Bangladesh 996
HK - Hong Kong 924
DE - Germania 825
CA - Canada 732
FR - Francia 500
UA - Ucraina 469
FI - Finlandia 340
IN - India 299
IE - Irlanda 268
SE - Svezia 251
AR - Argentina 247
MX - Messico 246
NL - Olanda 199
TR - Turchia 185
PL - Polonia 183
ID - Indonesia 165
IQ - Iraq 136
ES - Italia 129
ZA - Sudafrica 128
DK - Danimarca 123
EC - Ecuador 122
IL - Israele 118
JP - Giappone 116
PK - Pakistan 101
AT - Austria 84
CO - Colombia 83
UZ - Uzbekistan 61
VE - Venezuela 60
MA - Marocco 58
AE - Emirati Arabi Uniti 54
LT - Lituania 48
PY - Paraguay 47
CL - Cile 45
PE - Perù 36
SA - Arabia Saudita 35
PH - Filippine 34
EG - Egitto 32
KE - Kenya 29
TN - Tunisia 29
MY - Malesia 28
CH - Svizzera 27
UY - Uruguay 23
AZ - Azerbaigian 22
CR - Costa Rica 22
DZ - Algeria 21
EU - Europa 21
BO - Bolivia 20
JO - Giordania 20
NP - Nepal 20
BE - Belgio 19
AU - Australia 18
DO - Repubblica Dominicana 15
HN - Honduras 15
RO - Romania 15
JM - Giamaica 14
KZ - Kazakistan 14
AL - Albania 13
CZ - Repubblica Ceca 13
OM - Oman 13
TW - Taiwan 12
GT - Guatemala 11
AM - Armenia 10
HU - Ungheria 10
IR - Iran 10
NI - Nicaragua 10
PA - Panama 10
TH - Thailandia 10
GR - Grecia 9
SK - Slovacchia (Repubblica Slovacca) 9
BB - Barbados 8
KR - Corea 8
KW - Kuwait 8
LB - Libano 8
MC - Monaco 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BY - Bielorussia 7
SN - Senegal 7
BH - Bahrain 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
HR - Croazia 6
LV - Lettonia 6
MD - Moldavia 6
QA - Qatar 6
RS - Serbia 6
SI - Slovenia 6
BA - Bosnia-Erzegovina 5
CI - Costa d'Avorio 5
MK - Macedonia 5
Totale 52.168
Salva come PNG Salva come JPEG
Città #
Dallas 4.545
Singapore 2.480
Ashburn 1.525
San Jose 1.505
Chicago 1.311
Beijing 1.263
Los Angeles 1.096
Hong Kong 868
Ho Chi Minh City 619
Moscow 588
Salt Lake City 554
Southend 540
Milan 512
New York 512
Buffalo 449
Chandler 443
Fairfield 411
Hanoi 379
Houston 343
Woodbridge 331
San Mateo 329
Tampa 313
Rome 310
Wilmington 285
The Dalles 281
Seattle 275
Santa Clara 268
São Paulo 261
Dublin 259
Elk Grove Village 249
Ann Arbor 243
Council Bluffs 243
Cambridge 237
Falls Church 232
Lauterbourg 231
Hefei 221
Boardman 209
Helsinki 209
Jacksonville 189
Ottawa 188
Dearborn 162
Pisa 161
Beauharnois 156
Warsaw 155
Portsmouth 153
Orem 151
Montreal 147
Munich 145
Stevenage 141
Sterling 123
Florence 122
Mexico City 121
Brooklyn 118
Frankfurt am Main 116
Lancaster 116
Dong Ket 115
London 115
Lawrence 106
Tel Aviv 105
Denver 99
Tokyo 99
Poplar 95
Amsterdam 93
Istanbul 91
Phoenix 91
Miami 90
Atlanta 88
Chennai 87
Toronto 87
Johannesburg 86
Rio de Janeiro 85
Stockholm 82
Da Nang 77
Naples 74
Columbus 72
Dulles 72
Nuremberg 72
Bologna 65
Turin 61
Detroit 60
Haiphong 60
Belo Horizonte 57
Manchester 56
Tashkent 56
San Diego 54
Figino 53
Lappeenranta 53
Washington 53
Genoa 52
Boston 51
Turku 51
Kansas City 49
Palermo 48
Brasília 46
San Francisco 45
Baghdad 44
Biên Hòa 44
Bari 43
Curitiba 43
Querétaro 43
Totale 30.561
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.843
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.703
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.576
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 729
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 696
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 615
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 431
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 405
A simple echocardiographic score to rule out cardiac amyloidosis 388
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 378
The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians 371
A simple echocardiographic score to rule out cardiac amyloidosis 354
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 325
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Adrenergic activation in heart failure: blockade or rebalance? 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 307
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 300
Eligibility for vericiguat in a real‐world, contemporary heart failure population 298
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 298
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 297
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 295
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 292
[Ten perspectives for research and innovation in cardiac amyloidosis] 291
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 291
Screening the health status of people working in a university 290
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 284
How to take arms against central apneas in heart failure 281
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 281
Sex-related differences in chronic heart failure 280
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 278
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 278
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 269
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 269
Cardiac light-chain deposition disease relapsing in the transplanted heart 269
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 268
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 268
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 268
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 266
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 265
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 264
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 262
Atrial amyloidosis: mechanisms and clinical manifestations 261
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 260
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 260
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 259
null 258
Valve disease in cardiac amyloidosis: an echocardiographic score 258
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 258
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 258
Update sui biomarcatori nello scompenso cardiaco. 257
Biomarkers for the diagnosis and management of heart failure: New frontiers 256
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 256
RNA-targeting and gene editing therapies for transthyretin amyloidosis 255
Disease features and management of cardiomyopathies in women 254
null 253
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 243
Biomarkers for the diagnosis and management of heart failure 241
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 241
The search for efficient diagnostic and prognostic biomarkers of heart failure 239
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 239
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 238
Role of Imaging in Cardiomyopathies 235
Valvular heart disease in patients with cardiac amyloidosis 235
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 235
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 235
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 234
Renin profiling predicts neurohormonal response to sacubitril/valsartan 233
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 231
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 230
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 230
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 229
null 228
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 227
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 227
null 226
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 225
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 225
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 224
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 223
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 223
Prognostic value of plasma Renin activity in heart failure. 222
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 220
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 219
null 218
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 218
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 217
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 216
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 215
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis 215
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 214
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 214
Molecular autopsy of sudden cardiac death in the genomics era 214
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure 213
Totale 32.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 0 0 311
2021/20221.911 161 295 80 196 74 67 201 333 141 195 36 132
2022/20231.334 109 110 62 140 164 175 36 120 251 30 82 55
2023/20241.331 76 36 239 101 73 120 102 65 51 75 55 338
2024/202513.797 112 134 488 200 420 492 1.186 2.129 814 2.025 3.141 2.656
2025/202629.484 1.478 4.075 3.965 3.855 2.791 1.808 2.690 1.350 1.812 1.912 2.032 1.716
Totale 52.600